AmBisome administration for Candida albicans shunt infections.
Giuseppe V L
GV
De Socio
Maurizio
M
Fiorio
Giuliano
G
Stagni
D000368:Aged; D000666:Amphotericin B / Q000009:adverse effects / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002177:Candidiasis / Q000188:drug therapy* / Q000382:microbiology; D006801:Humans; D008297:Male; D016459:Prosthesis-Related Infections / Q000188:drug therapy* / Q000382:microbiology; D020521:Stroke / Q000150:complications / Q000601:surgery; D017287:Ventriculoperitoneal Shunt
D000935:Antifungal Agents; C068538:liposomal amphotericin B; D000666:Amphotericin B